Showing results (1241-1250 of 5,986) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|June 23, 2019
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic LeukemiaSankaranarayanan Kannan, Marisa J L Aitken, Shelley M Herbrich, et al.
Molecular Cancer Therapeutics|June 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid TumorsGiuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, et al.
Molecular Cancer Therapeutics|June 28, 2019
Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical OutcomesMathilde Couëtoux du Tertre, Maud Marques, Lise Tremblay, et al.
Molecular Cancer Therapeutics|July 3, 2019
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in KRAS-Mutant CancersAdam Stewart, Elizabeth A Coker, Sebastian Pölsterl, et al.
Molecular Cancer Therapeutics|October 20, 2021
Anastrozole Regulates Fatty Acid Synthase in Breast CancerJunmei Cairns, James N Ingle, Krishna R Kalari, et al.
Molecular Cancer Therapeutics|October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal CarcinomatosisChristopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.
Molecular Cancer Therapeutics|October 20, 2021
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL-Specific Degrader DT2216Dinesh Thummuri, Sajid Khan, Patrick W Underwood, et al.
Molecular Cancer Therapeutics|October 20, 2021
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 ActivityTommaso Balestra, Maria Cristina Manara, Maria Antonella Laginestra, et al.
Molecular Cancer Therapeutics|July 5, 2019
In Vivo ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in MelanomaIleine M Sanchez, Timothy J Purwin, Inna Chervoneva, et al.
Molecular Cancer Therapeutics|July 10, 2019
Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca2+ Release and Cyclic AMPAtul Anand, Bin Liu, Jano Dicroce Giacobini, et al.
Pageof 599